Review maps limited evidence for animal-assisted SCI rehab: full analysis

Animal-assisted treatment is getting a closer look in spinal cord injury rehabilitation, but the evidence base is still early. A new scoping review published May 30, 2026, in Spinal Cord identified just 10 empirical studies involving adults with spinal cord injury, despite screening 257 unique records across seven databases. The authors conclude that canine- and equine-assisted treatment may offer benefits across physical and psychological outcomes, while stopping short of recommending routine clinical use because the literature remains limited and methodologically uneven. (nature.com)

That gap in evidence is part of why this paper matters. Animal-assisted treatment has been used in neurorehabilitation for years, and the review notes that interest has extended to outcomes such as gait, respiratory function, and well-being. But until now, there had been no dedicated overview of the spinal cord injury literature. The paper also reflects a terminology shift in the field: the authors use “animal-assisted treatment,” aligned with newer international efforts to distinguish structured, goal-directed clinical treatment from broader animal-assisted activities or support programs. IAHAIO has been updating its terminology and standards, including minimum standards for research and a move toward the broader umbrella term “animal-assisted services.” (nature.com)

In the review itself, the evidence split evenly between canine- and equine-assisted interventions. Among canine studies, the authors report reductions in muscle activity, pushrim kinetics, and some cardiovascular measures, along with faster wheelchair propulsion or course completion in several studies. At the same time, pain severity, pain interference, positive affect, and salivary cortisol did not consistently improve. Among equine studies, the review found improvements in spasticity, weight distribution, ankle range of motion, and perceived social or motivational benefits, though standing balance results were mixed and some gains appeared to diminish over time. (nature.com)

The broader literature helps put those findings in context. A 2024 randomized controlled trial in adult musculoskeletal rehabilitation described dog-assisted therapy as a promising adjunct, but also emphasized that the field still suffers from inconsistent terminology, limited randomization, and too few multicenter studies to support firm conclusions. A prior systematic review of animal-assisted therapy in neurological diseases in adults likewise found encouraging but mostly short-term findings, including in spinal cord injury, while calling for stronger evidence on how to achieve durable effects. (bmccomplementmedtherapies.biomedcentral.com)

Industry and expert commentary around animal-assisted services has increasingly focused on two issues that veterinary teams will recognize immediately: rigor and welfare. IAHAIO’s recent materials stress clearer definitions, research standards, and attention to the well-being of animals involved in treatment programs. Separate commentary in the animal-assisted services literature has also highlighted the need for professional standards, stronger empirical methods, and public policy clarity. In other words, enthusiasm for these programs is no longer enough on its own; the field is being pushed to show not just whether they help, but under what conditions, for whom, and at what cost to animals and institutions. (iahaio.org)

Why it matters: For veterinary professionals, this review sits at the intersection of rehabilitation medicine, human-animal interaction, and animal welfare oversight. Practices and organizations involved in therapy dog or equine programs may see the paper as validation that these interventions can contribute meaningful functional and psychosocial support in human rehabilitation. But the bigger takeaway is caution: the current evidence base is too small and heterogeneous to justify broad claims, and future program credibility will depend on standardized protocols, clearer outcome measures, and explicit welfare safeguards for therapy animals. That matters for veterinarians advising facilities, screening animals for suitability, monitoring stress or overwork, and helping pet parents understand the difference between structured clinical treatment and less formal animal visitation models. (nature.com)

What to watch: The next important signals will be prospective controlled studies, especially multicenter trials with longer follow-up, plus more formal incorporation of animal welfare metrics into study design and reporting. If that happens, the field may move from promising adjunctive care toward a more standardized part of interdisciplinary rehabilitation. For now, the review’s message is more measured: there’s enough evidence to justify further study, but not enough to settle practice. (nature.com)